Prevnar News and Research

RSS
One-shot vaccine passes key preclinical test in newborn monkey models

One-shot vaccine passes key preclinical test in newborn monkey models

Important vaccines that should not be missed by adults, elders and pregnant women

Important vaccines that should not be missed by adults, elders and pregnant women

Medical advisory panel recommends new pneumonia vaccine for seniors

Medical advisory panel recommends new pneumonia vaccine for seniors

Prevalence of bacterial meningitis drops in the United States

Prevalence of bacterial meningitis drops in the United States

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Infant vaccination against pneumonia helps protect elderly

Infant vaccination against pneumonia helps protect elderly

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

EC approves Pfizer’s Prevenar 13 to prevent pneumococcal disease

EC approves Pfizer’s Prevenar 13 to prevent pneumococcal disease

NIAID-funded study to evaluate PPSV23 and PCV13 in Phase Iib pneumococcal trial

NIAID-funded study to evaluate PPSV23 and PCV13 in Phase Iib pneumococcal trial

Saint Louis University to participate in PPV23 vaccine trial for pneumonia

Saint Louis University to participate in PPV23 vaccine trial for pneumonia

Top-line data from Pfizer’s Prevenar 13 Phase 3 trial on pneumococcal disease

Top-line data from Pfizer’s Prevenar 13 Phase 3 trial on pneumococcal disease

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer’s Prevenar 13 gets US approval for adults

Pfizer’s Prevenar 13 gets US approval for adults

FDA approves Prevnar 13 pneumococcal conjugate vaccine for adults 50 and older

FDA approves Prevnar 13 pneumococcal conjugate vaccine for adults 50 and older